NGM·Healthcare·$76M·#446 / 520 in Healthcare
SERA Sera Prognostics, Inc.
23HIGH RISK
CATEGORY BREAKDOWN
GROWTH8
QUALITY0
STABILITY35
VALUATION0
GOVERNANCE76
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+5.2%
8
> 50% strong
Gross Margin
Revenue retained after direct costs
-102.5%
0
> 50% strong
Cash Runway
Months of cash at current burn rate
2 months
3
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
3.1%
98
< 25% strong
Price / Sales
Market cap relative to trailing revenue
937.9x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-45061
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
11.7%
68
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.4%
92
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE SERA WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when SERA's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.